Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
Supply of products for the treatment of Blood Disorders including Haemophilia A & B to NHS Scotland.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Bio Products Laboratory | 07343036 | - | 2 lots Factor IX - High Purity Factor IX · Factor X | LOBBYIST Garnish Hall Enterprises Ltd (1 quarter) |
| CSL Behring | 01622483 | - | 5 lots Factor XIII - Plasma Derived · Von willebrands factor / Factor VIII · Fibrinogen Concentrate · Prothrombin Complex dried · Eftrenonacog alfa (rFIX EHL) | - |
| LFB Biopharmaceuticals Ltd | 06058711 | - | 3 lots Von willebrands factor - Plasma Derived · Fibrinogen Concentrate · Recombinant Factor VII | - |
| Novo Nordisk Ltd | 01118740 | - | 4 lots Factor XIII - Recombinant · Enhanced Half-life Recombinant Factor VIII · Nonacog beta pegol (rFIX EHL) · Recombinant Factor VII | LOBBYIST WA Communications Ltd (7 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (1 quarter) |
| Octapharma Ltd | 02372699 | - | 5 lots Standard Half-life Recombinant Factor VIII · Von willebrands factor / Factor VIII · Fibrinogen Concentrate · Prothrombin Complex dried · Fresh Frozen Plasma (all blood groups) | - |
| Pfizer Limited | 00526209 | - | 2 lots Standard Half-life Recombinant Factor VIII · rFIX - Standard Half Life | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Ovid Consulting Ltd (3 quarters) Hanover Communications International Limited (3 quarters) MHP Communications (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
| Roche Products Ltd | 00100674 | - | 1 lot Enhanced Half-life Recombinant Factor VIII | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
| Swedish Orphan Biovitrum Ltd | 04369760 | - | 2 lots Enhanced Half-life Recombinant Factor VIII · Eftrenonacog alfa (rFIX EHL) | - |
| Takeda UK Limited | 03362860 | - | 7 lots Standard Half-life Recombinant Factor VIII · Factor VIII Inhibitor Bypassing Fraction · Von willebrands factor - Recombinant · Prothrombin Complex dried · Protein C Concentrate · rFIX - Standard Half Life · Porcine Factor VIII - susoctocog alfa | LOBBYIST Hill & Knowlton Limited (3 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (2 quarters) Burkitt Communications Ltd (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP Sir Kevin Barron— Employment and earnings (former) |
This procurement was divided into 21 lots, each awarded separately. 30 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Standard Half-life Recombinant Factor VIII | £9,070,137 initial term | 3 | Takeda UK Limited Pfizer Limited Octapharma Ltd | complete |
| Lot 2 Enhanced Half-life Recombinant Factor VIII | £7,134,755 initial term | 2 | Novo Nordisk Ltd Swedish Orphan Biovitrum Ltd | complete |
| Lot 3 Enhanced Half-life Recombinant Factor VIII | £40,327,988 initial term | 1 single bid — no competition | Roche Products Ltd | complete |
| Lot 4 Eftrenonacog alfa (rFIX EHL) | £1,674,113 initial term | 1 single bid — no competition | Swedish Orphan Biovitrum Ltd | complete |
| Lot 5 Eftrenonacog alfa (rFIX EHL) | £14,643,514 initial term | 1 single bid — no competition | CSL Behring | complete |
| Lot 6 Nonacog beta pegol (rFIX EHL) | £490,820 initial term | 1 single bid — no competition | Novo Nordisk Ltd | complete |
| Lot 7 rFIX - Standard Half Life | £4,604,830 initial term | 2 | Takeda UK Limited Pfizer Limited | complete |
| Lot 8 Recombinant Factor VII | £604,584 initial term | 2 | Novo Nordisk Ltd LFB Biopharmaceuticals Ltd | complete |
| Lot 9 Porcine Factor VIII - susoctocog alfa | £1 initial term | 1 single bid — no competition | Takeda UK Limited | complete |
| Lot 10 Factor VIII Inhibitor Bypassing Fraction | £502,964 initial term | 1 single bid — no competition | Takeda UK Limited | complete |
| Lot 11 Factor IX - High Purity Factor IX | £1 initial term | 1 single bid — no competition | Bio Products Laboratory | complete |
| Lot 12 Factor X | £1 initial term | 1 single bid — no competition | Bio Products Laboratory | complete |
| Lot 13 Factor XIII - Plasma Derived | £1 initial term | 1 single bid — no competition | CSL Behring | complete |
| Lot 14 Factor XIII - Recombinant | £129,113 initial term | 1 single bid — no competition | Novo Nordisk Ltd | complete |
| Lot 15 Von willebrands factor / Factor VIII | £532,441 initial term | 2 | Octapharma Ltd CSL Behring | complete |
| Lot 16 Von willebrands factor - Plasma Derived | £1,196,460 initial term | 1 single bid — no competition | LFB Biopharmaceuticals Ltd | complete |
| Lot 17 Von willebrands factor - Recombinant | £2,815,053 initial term | 1 single bid — no competition | Takeda UK Limited | complete |
| Lot 18 Fibrinogen Concentrate | £186,346 initial term | 3 | Octapharma Ltd CSL Behring LFB Biopharmaceuticals Ltd | complete |
| Lot 19 Prothrombin Complex dried | £1,380,752 initial term | 2 | Takeda UK Limited Octapharma Ltd CSL Behring | complete |
| Lot 20 Protein C Concentrate | £1 initial term | 1 single bid — no competition | Takeda UK Limited | complete |
| Lot 21 Fresh Frozen Plasma (all blood groups) | £1 initial term | 1 single bid — no competition | Octapharma Ltd | complete |
Government spending data: These suppliers have received £400,481,344 in 3,368 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care, NHS England, Manchester University NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust and 17 more public bodies (2018-04-04 to 2026-03-31).